Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Tamsulosin Hydrochloride Sustained-release Capsules

Approval Number

国药准字H20050392

Company江苏恒瑞医药股份有限公司

Registration Date

August 31, 2020

Drug Information

Generic Name

盐酸坦索罗辛缓释胶囊

Brand Name

恒瑞

Dosage Form

胶囊剂

Strength

0.2mg

Drug Type

化学药品

Registration Date

August 31, 2020

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy